Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
aforementioned, altering, Anticancer, bone, CMS, Digital, doubt, fining, IDTA, introduced, IRA, Irish, issuer, legitimacy, Meta, mobility, morphogenetic, neuron, ONYX, Parliament, passed, recipient, staffing, survival, version
Removed:
adjust, attributed, background, bioresearch, commerce, Conference, confounded, confounding, consistently, cycle, defer, detection, domestic, endpoint, epidemic, essential, exploratory, impacted, infected, largely, missed, missing, overseeing, pandemic, procuring, rejection, remote, remotely, resume, resumed, ripple, routine, scheduled, shipping, SITC, skipping, spread, supportive, transport, undertaken, vaccination, Virtual, worker
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view